HAMLET – A urogynecologist with FirstHealth Urogynecology in Hamlet, Dr. Harris-Hicks is seeking patients to participate voluntarily in a clinical trial involving a study drug for overactive bladder.
While it’s a subject that most women would prefer not to discuss, overactive bladder (or urgency urinary incontinence) affects as many as 40 percent of the women in the U.S.
The condition is often considered a “normal part of aging”, but Janet Harris-Hicks, M.D., says otherwise.
“Urinary incontinence is not a normal part of aging,” she says. “This is the first statement I make when doing public speaking. The second is ‘and there are treatment options that actually work.’”
The study’s aim is to see if giving the study drug in a different way can improve control over the symptoms of frequency and urgency associated with overactive bladder.
A woman may be able to take part in the study if she is 18 years or older, has had symptoms of overactive bladder for six months or more, and meets other required eligibility criteria.
The duration of the study is at least 25 weeks and up to 53 weeks, depending on the number of times the patient receives the study drug. During this study, a participant will have seven to 12 scheduled clinic visits and some telephone contact from the study’s staff.
Women who qualify and choose to participate will receive study-related care and physician monitoring at no cost.
To learn more about the study for overactive bladder or to find out if you are eligible, call (910) 205-8909. FirstHealth Urogynecology is located at 108 Endo Lane, Suite 1, in Hamlet, North Carolina.